<code id='07695024E3'></code><style id='07695024E3'></style>
    • <acronym id='07695024E3'></acronym>
      <center id='07695024E3'><center id='07695024E3'><tfoot id='07695024E3'></tfoot></center><abbr id='07695024E3'><dir id='07695024E3'><tfoot id='07695024E3'></tfoot><noframes id='07695024E3'>

    • <optgroup id='07695024E3'><strike id='07695024E3'><sup id='07695024E3'></sup></strike><code id='07695024E3'></code></optgroup>
        1. <b id='07695024E3'><label id='07695024E3'><select id='07695024E3'><dt id='07695024E3'><span id='07695024E3'></span></dt></select></label></b><u id='07695024E3'></u>
          <i id='07695024E3'><strike id='07695024E3'><tt id='07695024E3'><pre id='07695024E3'></pre></tt></strike></i>

          Home / Wikipedia / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:9322
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In